CHRONIC HEPATITIS D INFECTION
Clinical trials for CHRONIC HEPATITIS D INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS D INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS D INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to clear hepatitis b and d in 20-patient trial
Disease control CompletedThis early-stage study tested a new treatment approach for adults with chronic hepatitis B or D. Twenty participants received two medications in sequence: P1101 (a type of interferon) followed by an anti-PD1 drug. The main goal was to check safety and tolerability, while also loo…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE1 • Sponsor: PharmaEssentia • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Kidney-Friendly? early study checks hepatitis d drug in patients with impaired kidneys
Disease control CompletedThis early-stage study looked at how the drug bulevirtide behaves in people with chronic hepatitis D who also have normal or impaired kidney function. Researchers measured drug levels in the blood, its effect on bile acids, and overall safety. The study enrolled 41 adults and gav…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 26, 2026 18:26 UTC
-
Liver drug bulevirtide tested in people with liver problems
Knowledge-focused CompletedThis completed Phase 1 study looked at how the drug bulevirtide (Hepcludex) behaves in the body of people with normal liver function and those with liver impairment. Researchers measured drug levels in the blood and how quickly it is cleared. The study involved 74 participants an…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC